- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03648008
Postoperative Analgesic Effect of Hydromorphone on Partial Pulmonary Resection Under Video-assisted Thoracoscopy
September 24, 2018 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
Postoperative Analgesic Effect of Hydromorphone on Chinese Patients Receiving Partial Pulmonary Resection Under Video-assisted Thoracoscopy
Postoperative pain remains relatively high within 48h for Chinese patients who receive video-assisted thoracoscopic surgery.
Multimodal analgesia combines several agents and/or techniques to function on diverse nociceptive mechanisms to enhance pain relief and lessen side effect.
Hydromorphone is a hydrogenated ketone of morphine and approximately 5-10 times more potent.
There lacks about efficacy and efficiency of hydromorphone in electrical pump for patient controlled intravenous analgesic (PCIA).
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
171
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- The Second Affiliated Hospital of Zhejiang University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 70≥ Age ≥18
- Selective operation lung section with video-assisted thoracic surgery (VATS)
- III ≥ American Society of Anesthesiologists classification (ASA classification) ≥I
- Patients informed and agreed to join the study
Exclusion Criteria:
- Abnormal function of liver and kidney
- Allergic- dependence history of alcohol, opioids and Local anesthetics
- No noncompliance
- Mental disease history,language communication disorder,cicatricial diathesis
- Underweight or overweight(BMI<18 or >30)
- Patients not suitable for clinical subjects for other reasons
- Sedatives, analgesics, antiemetic drugs and anti pruritus drugs were used within 24 hours before the operation.
- History of previous abnormal anaesthesia
- Women during pregnancy or lactation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group M
Drug: Morphine Background: No Bolus infusion: 0.015 mg*kg-1
|
0.015 mg*kg-1 bolus without background infusion for group M Drug is administered through PCIA pump.
|
|
Experimental: Group NBH
Drug: Hydromorphone Background: No Bolus infusion: 0.002 mg*kg-1
|
0.002 mg*kg-1 bolus with 0.002 mg*kg-1 background infusion for group BH 0.002 mg*kg-1 bolus without background infusion for group NBH Drug is administered through PCIA pump.
|
|
Experimental: Group BH
Drug: Hydromorphone Background: 0.002 mg*kg-1*h-1 Bolus infusion: 0.002 mg*kg-1
|
0.002 mg*kg-1 bolus with 0.002 mg*kg-1 background infusion for group BH 0.002 mg*kg-1 bolus without background infusion for group NBH Drug is administered through PCIA pump.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rest pain assessment at 0.5 hour after tracheal extubation
Time Frame: 0.5 hour after tracheal extubation
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
0.5 hour after tracheal extubation
|
|
Rest pain assessment at 8 p.m. surgery day
Time Frame: 8 p.m. at surgery day
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at surgery day
|
|
Activity pain assessment at 8 p.m. surgery day
Time Frame: 8 p.m. at surgery day
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at surgery day
|
|
Rest pain assessment at 8 a.m. at first day after surgery
Time Frame: 8 a.m. at first day after surgery
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 a.m. at first day after surgery
|
|
Activity pain assessment at 8 a.m. at first day after surgery
Time Frame: 8 a.m. at first day after surgery
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 a.m. at first day after surgery
|
|
Rest pain assessment at 8 p.m. at first day after surgery
Time Frame: 8 p.m. at first day after surgery
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at first day after surgery
|
|
Activity pain assessment at 8 p.m. at first day after surgery
Time Frame: 8 p.m. at first day after surgery
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at first day after surgery
|
|
Rest pain assessment at 8 a.m. at second day after surgery
Time Frame: 8 a.m. at second day after surgery
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 a.m. at second day after surgery
|
|
Activity pain assessment at 8 a.m. at second day after surgery
Time Frame: 8 a.m. at second day after surgery
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 a.m. at second day after surgery
|
|
Rest pain assessment at 8 p.m. at second day after surgery
Time Frame: 8 p.m. at second day after surgery
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at second day after surgery
|
|
Activity pain assessment at 8 p.m. at second day after surgery
Time Frame: 8 p.m. at second day after surgery
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at second day after surgery
|
|
Rest pain assessment at 8 a.m. at third day after surgery
Time Frame: 8 a.m. at third day after surgery
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 a.m. at third day after surgery
|
|
Activity pain assessment at 8 a.m. at third day after surgery
Time Frame: 8 a.m. at third day after surgery
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 a.m. at third day after surgery
|
|
Rest pain assessment at 8 p.m. at third day after surgery
Time Frame: 8 p.m. at third day after surgery
|
Visual Analogue Scale/Score to assess pain at rest.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at third day after surgery
|
|
Activity pain assessment at 8 p.m. at third day after surgery
Time Frame: 8 p.m. at third day after surgery
|
Visual Analogue Scale/Score to assess pain on coughing.
VAS range from 0 to 100 millimeter.
And 0 stands for no pain, while 100 stands for worst pain.
Lower value is better.
|
8 p.m. at third day after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ratio of Nausea
Time Frame: 8 p.m. at surgery day
|
Record whether patients experience nausea
|
8 p.m. at surgery day
|
|
Ratio of Vomiting
Time Frame: 8 p.m. at surgery day
|
Record whether patients experience vomiting and how many times do they experience
|
8 p.m. at surgery day
|
|
Ratio of Nausea
Time Frame: 8 a.m. at first day after surgery
|
Record whether patients experience nausea
|
8 a.m. at first day after surgery
|
|
Ratio of Vomiting
Time Frame: 8 a.m. at first day after surgery
|
Record whether patients experience vomiting and how many times do they experience
|
8 a.m. at first day after surgery
|
|
Ratio of Nausea
Time Frame: 8 p.m. at first day after surgery
|
Record whether patients experience nausea
|
8 p.m. at first day after surgery
|
|
Ratio of Vomiting
Time Frame: 8 p.m. at first day after surgery
|
Record whether patients experience vomiting and how many times do they experience
|
8 p.m. at first day after surgery
|
|
Ratio of Nausea
Time Frame: 8 a.m. at second day after surgery
|
Record whether patients experience nausea
|
8 a.m. at second day after surgery
|
|
Ratio of Vomiting
Time Frame: 8 a.m. at second day after surgery
|
Record whether patients experience vomiting and how many times do they experience
|
8 a.m. at second day after surgery
|
|
Ratio of Nausea
Time Frame: 8 p.m. at second day after surgery
|
Record whether patients experience nausea
|
8 p.m. at second day after surgery
|
|
Ratio of Vomiting
Time Frame: 8 p.m. at second day after surgery
|
Record whether patients experience vomiting and how many times do they experience
|
8 p.m. at second day after surgery
|
|
Ratio of Nausea
Time Frame: 8 a.m. at third day after surgery
|
Record whether patients experience nausea
|
8 a.m. at third day after surgery
|
|
Ratio of Vomiting
Time Frame: 8 a.m. at third day after surgery
|
Record whether patients experience vomiting and how many times do they experience
|
8 a.m. at third day after surgery
|
|
Ratio of Nausea
Time Frame: 8 p.m. at third day after surgery
|
Record whether patients experience nausea
|
8 p.m. at third day after surgery
|
|
Ratio of Vomiting
Time Frame: 8 p.m. at third day after surgery
|
Record whether patients experience vomiting and how many times do they experience
|
8 p.m. at third day after surgery
|
|
Total Analgesia usage
Time Frame: 8 p.m. at surgery day
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump
|
8 p.m. at surgery day
|
|
Total Antiemetic usage
Time Frame: 8 p.m. at surgery day
|
Sum up any antiemetic
|
8 p.m. at surgery day
|
|
Total Analgesia usage
Time Frame: 8 a.m. at first day after surgery
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump from last time point
|
8 a.m. at first day after surgery
|
|
Total Antiemetic usage
Time Frame: 8 p.m. at first day after surgery
|
Sum up any antiemetic from last time point
|
8 p.m. at first day after surgery
|
|
Total Analgesia usage
Time Frame: 8 p.m. at first day after surgery
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump from last time point
|
8 p.m. at first day after surgery
|
|
Total Analgesia usage
Time Frame: 8 a.m. at second day after surgery
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump from last time point
|
8 a.m. at second day after surgery
|
|
Total Antiemetic usage
Time Frame: 8 a.m. at second day after surgery
|
Sum up any antiemetic from last time point
|
8 a.m. at second day after surgery
|
|
Total Analgesia usage
Time Frame: 8 p.m. at second day after surgery
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump from last time point
|
8 p.m. at second day after surgery
|
|
Total Antiemetic usage
Time Frame: 8 p.m. at second day after surgery
|
Sum up any antiemetic from last time point
|
8 p.m. at second day after surgery
|
|
Total Analgesia usage
Time Frame: 8 a.m. at third day after surgery
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump from last time point
|
8 a.m. at third day after surgery
|
|
Total Antiemetic usage
Time Frame: 8 a.m. at third day after surgery
|
Sum up any antiemetic from last time point
|
8 a.m. at third day after surgery
|
|
Total Analgesia usage
Time Frame: 8 p.m. at third day after surgery
|
Sum up any extra analgesia when analgesic failure (VAS persistently > 4) with PCIA pump from last time point
|
8 p.m. at third day after surgery
|
|
Total Antiemetic usage
Time Frame: 8 p.m. at third day after surgery
|
Sum up any antiemetic from last time point
|
8 p.m. at third day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 5, 2018
Primary Completion (Actual)
September 1, 2018
Study Completion (Actual)
September 1, 2018
Study Registration Dates
First Submitted
August 13, 2018
First Submitted That Met QC Criteria
August 23, 2018
First Posted (Actual)
August 27, 2018
Study Record Updates
Last Update Posted (Actual)
September 26, 2018
Last Update Submitted That Met QC Criteria
September 24, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
National and Kapodistrian University of AthensCompletedPostoperative Pain, Acute | Postoperative Pain, Chronic | Postoperative Pain After Thoracic SurgeryGreece
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPostoperative Pain | Postoperative Pain Management | Postoperative Pain in Orthopaedics
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Children's National Research InstituteVentureWellRecruitingPostoperative Pain | Acute Pain | Acute Pain, PostoperativeUnited States
-
University of MalayaActive, not recruitingPostoperative Pain | Postoperative Pain ManagementMalaysia
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
Clinical Trials on Morphine
-
Hospital Central do FunchalRecruitingAnalgesia | Patient Satisfaction | Post Operative Pain | Cesarean Section Pain | Analgesia ObstetricalPortugal
-
Indiana UniversityCompletedNeonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome | Neonatal Opioid WithdrawalUnited States
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingAnalgesia | Nausea and Vomiting, Postoperative | Morphine | Morphine Adverse Reaction | Morphine Induced Pruritis | Spinal AnalgesiaBelgium
-
Javelin PharmaceuticalsCompletedPain, PostoperativeUnited States
-
Javelin PharmaceuticalsCompleted
-
Mahidol UniversityCompletedLung Diseases | Solitary MassThailand
-
University of MonastirCompletedTitrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings (TIMORNEB)Acute Pain | Post-Traumatic HeadacheTunisia
-
University of Colorado, DenverCompletedScoliosis | Pain Management | Spinal FusionUnited States
-
Javelin PharmaceuticalsCompletedPost-Operative Pain | Third Molar Extraction
-
Hospital Universitario de CaracasCompletedPostoperative Pain | Cesarean Section | Obstetric AnesthesiaVenezuela